...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> AYOXXA and Märzhäuser Introduce a Benchtop Device for Protein Multiplex Analysis
08/22/16
> RedHill Biopharma Provides 2016 Semi-Annual R&D Update
08/11/16
> Selvita Signs a Significant Collaboration with the University of California, San Francisco (UCSF)
08/09/16
> The World’s First Smart Insulin Pens with Automatic Wireless Data Transfer (868 MHz or Bluetooth®)
08/04/16
> ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta®
08/04/16
> RedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple Sclerosis
08/01/16
> Trod Medical Receives a New Patent Allowance for Prostate Focal Therapy Encage™ Device
08/01/16
> Epidarex Capital Creates Nodthera Limited
07/28/16
> ARTES and Burnet Institute Join Forces to Develop Novel Hepatitis C Vaccine
07/26/16
> FDA Grants QIDP and Fast Track Designations to MCB3837, Morphochem’s Novel Intravenous Antibacterial to Treat C. Difficile Infections
07/25/16
> RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection
07/21/16
> Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
07/20/16
> HYD Pharma Receives Ethical Approval for Phase 2 Clinical Trial Investigating the Anticancer Effect of Deuterium Depletion in CLL
07/18/16
> Vetter Provides Insights into Its Long-Term Expansion Plans That Include the Purchasing of Property in the City of Des Plaines
07/15/16
> RedHill Biopharma Announces Research Collaboration with NIH for Potential Ebola Treatment
07/13/16
> Study Confirms Analytical Precision Of MammaTyper® In Molecular Breast Cancer Typing
07/12/16
> International Collaboration to Create New Cancer Models to Accelerate Research
07/11/16
> Australian Drug Discovery Company AdAlta, Announces IPO to Accelerate New Therapies for Lung Fibrosis
07/08/16
> Claristep® Filtration System: Fast, Easy and Reliable Sample Preparation
07/07/16
> Sartorius Stedim BioOutsource Introduces New Released N-Glycan Assay
07/07/16
> RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT™ for Migraines with Grupo JUSTE in Spain and Additional Potential Territories
07/06/16
> Atriva Therapeutics Completes Transfer of Co-Infection Patent
07/05/16
> SomantiX, PharmBioTec and Pharmacelsus Receive €1.5M EUROSTARS Grant for the Small Molecule Preclinical Development Program
06/30/16
> Zytoprotec Completes Enrollment in Phase II Study With Novel Peritoneal Dialysis Fluid
06/30/16
> First-In-Human Study of Immbio’s Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
06/30/16
> BoneAlbumin™ Induces Better Bone Formation
06/29/16
> Avita Medical Awarded USD 7.96m in BARDA Extension Deal
06/27/16
> RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn’s Disease Associated with MAP Infection
06/23/16
> Morphochem’s Investigational New Drug (IND) Application Accepted by the FDA – Novel Antibacterial for Intravenous Treatment of Clostridium difficile Infections (CDI), MCB3837/MCB3681, Can Now Move into Phase 2
06/22/16
> RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors
06/22/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 43